Psychiatric Hospitals in Australia - Industry Market Research Report

IBISWorld
December 3, 2012
28 Pages - SKU: IBSS4959593
Austria Pharmaceuticals and Healthcare Report Q4 2014
9/17/2014 | published by: Business Monitor International
Austria Pharmaceuticals and Healthcare Report Q4 2014 BMI View: BMI has upwardly revised its pharmaceutical and healthcare forecasts for Austria, reflectingthe country's improving economic prospects and attractiveness of these sectors in particular. The UnitedStates Commerce department  |  read more...
USD 1,295
Ireland Pharmaceuticals and Healthcare Report Q4 2014
9/17/2014 | published by: Business Monitor International
Ireland Pharmaceuticals and Healthcare Report Q4 2014 BMI View: The US government and the OECD recent proposals to discourage corporate inversion posedownside risk to the rate of M&A deals that opt to establish their new headquarters'  |  read more...
USD 1,295
Myanmar Pharmaceuticals and Healthcare Report Q4 2014
9/17/2014 | published by: Business Monitor International
Myanmar Pharmaceuticals and Healthcare Report Q4 2014 BMI View: While the current medical gap will attract some foreign investors into Myanmar, we highlightthat the lack of basic infrastructure and political instability will potentially affect the growth  |  read more...
USD 1,295
United States Pharmaceuticals and Healthcare Report Q4 2014
9/17/2014 | published by: Business Monitor International
United States Pharmaceuticals and Healthcare Report Q4 2014 BMI View: The US pharmaceutical market presents strong commercial opportunities across the industry.Total US pharmaceutical sales reached USD347.2bn in 2013 - more than three times the size of  |  read more...
USD 1,295
Bulgaria Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
Bulgaria Pharmaceuticals and Healthcare Report - Q4 2014 BMI View: The parlous situation of the NHIF and the inability of the Bulgarian parliament to agree on theinterim state budget present considerable risks to our 2014  |  read more...
USD 1,295
France Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
France Pharmaceuticals and Healthcare Report - Q4 2014 BMI View: Falling government consumption does not bode well for the pharmaceutical industry. Webelieve that in order to maintain appropriate pharmaceutical spending levels, the government will increaseits  |  read more...
USD 1,295
Gabon Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
Gabon Pharmaceuticals and Healthcare Report - Q4 2014 Oil-rich Gabon is one of the wealthiest countries in Sub-Saharan Africa, but a recent report compiled byMcKinsey suggests that a third of the country's population lives in  |  read more...
USD 1,295
Lebanon Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
Lebanon Pharmaceuticals and Healthcare Report - Q4 2014 BMI View: Lebanon's pharmaceutical sector is dominated by expensive drug imports as local firms'innovation and drug output remains low. We believe a multilateral approach to promoting generic  |  read more...
USD 1,295
China Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
China Pharmaceuticals and Healthcare Report - Q4 2014 BMI View: A more 'rational' use of pharmaceuticals through pharmacoeconomics, and a crackdown onillegal rebates and corruption in China's pharmaceutical market could hinder the sector's growth potential. However,  |  read more...
USD 1,295
Estonia Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
Estonia Pharmaceuticals and Healthcare Report - Q4 2014 BMI View: Against a backdrop of GDP contraction in Q114, Estonian pharmacy sales posted considerablegrowth, driven by demand for over-the-counter medicines and an uptick in prescriptions written.  |  read more...
USD 1,295
 

SELECT A LICENSE

    Online Download  USD 970  
    Global Site License  USD 2,425  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!